医学
指南
重症监护医学
间质性肺病
介绍
肺活检
肺移植
基因检测
肺
分级(工程)
疾病
儿科
梅德林
临床实习
肺科医师
多学科方法
重症监护
风险评估
作者
Matthew McGraw,Emily M. DeBoer,Jason P. Weinman,Gail H. Deutsch,Jennifer E. Pogoriler,Maureen B. Josephson,Geoffrey Kurland,Joshua A. Blatter,Alicia M. H. Casey,Robin R. Deterding,Elizabeth K. Fiorino,Lisa R. Young,Hayley Barnes,Vivek Balasubramaniam,Steven K. Brennan,Prangthip Charoenpong,Daniel I. Craven,Sharon Dell,Ralph Epaud,Martha P. Fishman
标识
DOI:10.1093/ajrccm/aamag375
摘要
BACKGROUND: Childhood interstitial lung diseases (chILD) are a heterogeneous group of rare disorders. In 2013, the American Thoracic Society (ATS) developed a guideline regarding the classification, evaluation, and management of children <2 years old with chILD. The current guideline provides updated recommendations regarding genetic testing, chest imaging, lung biopsy, and lung transplant referral. METHODS: The Grading of Recommendations, Assessment, Development, and Evaluation approach was used to form clinical questions, summarize evidence, and develop recommendations, following ATS policies and procedures. A multidisciplinary panel with expertise in chILD formulated recommendations addressing diagnostic tools and referral for lung transplant evaluation. RESULTS: Rapid and broad genetic testing is recommended for infants with chILD and respiratory failure (strong recommendation). Chest computed tomography (CT) remains an important part of the diagnostic evaluation (conditional recommendation). Surgical lung biopsy is recommended when there is urgency to identify a specific chILD disorder and genetic testing is not feasible, timely, or inconclusive; to identify histopathologic "treatable traits"; or to inform prognosis (strong recommendation). Referral for lung transplant evaluation is recommended for children with specific chILD disorders with predictable poor outcomes (strong recommendation). Repeat chest CT to aid decision-making, prognosis, and/or change therapies is suggested for children with chILD diagnosed before age 2 years (conditional recommendation). CONCLUSIONS: This guideline provides evidence-based recommendations for genetic testing, chest imaging, lung biopsy, and referral for lung transplant evaluation to improve the diagnostic evaluation and management of children <2 years with chILD. Implementing this guideline will hopefully increase genetic testing for chILD, inform the diagnostic evaluation and disease monitoring of chILD, and identify future research priorities for chILD.
科研通智能强力驱动
Strongly Powered by AbleSci AI